Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | DGKA | P23743 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26210276 | 0.97 | USP2 (0.52) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| SCHEMBL7606705 | 0.97 | USP2 (0.52) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| SCHEMBL13398700 | 0.90 | USP2 (0.50) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| Propane SCHEMBL5154976 | 0.89 | USP2 (0.58) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| Alcohol SCHEMBL2553945 | 0.89 | USP2 (0.58) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| SCHEMBL20438581 | 0.89 | USP2 (0.50) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| SCHEMBL325805 | 0.89 | KDM4E (0.52) | USP2KDM4EHSD17B10TSHRHTT | |
| SCHEMBL13024121 | 0.87 | USP2 (0.48) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| SCHEMBL20438574 | 0.87 | USP2 (0.48) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| SCHEMBL20438570 | 0.87 | USP2 (0.44) | USP2KDM4ELMNAALDH1A1DUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230372500-A1 | MULTI-ARM POLYMER CONJUGATES OF TLR AGONIST COMPOUNDS AND RELATED IMMUNOTHERAPEUTIC TREATMENT METHODS | NEKTAR THERAPEUTICS (US) | 2023-11-23 | — | — | US | disclosed |
| WO-2023219973-A1 | LOW MOLECULAR WEIGHT DISPERSANTS | CHEVRON ORONITE COMPANY LLC (US) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023219975-A1 | LUBRICANT ADDITIVES | CHEVRON ORONITE COMPANY LLC (US) | 2023-11-16 | — | — | WO | disclosed |
| US-11813241-B2 | Multi-arm polymeric prodrug conjugates of taxane-based compounds | NEKTAR THERAPEUTICS (US) | 2023-11-14 | — | — | US | disclosed |
| US-11744898-B2 | Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods | NEKTAR THERAPEUTICS (US) | 2023-09-05 | — | — | US | disclosed |
| US-11744925-B2 | Coatings | MICROVENTION, INC. (US) | 2023-09-05 | — | — | US | disclosed |
| WO-2023275241-A1 | CROSSLINKED HYALURONIC ACID COMPOSITION WITH LOCAL ANESTHETICS | BIOPOLIMERI S.R.L. (IT) | 2023-01-05 | — | — | WO | disclosed |
| EP-3331491-B1 | POLYMERS DERIVED FROM AMINO-FUNCTIONAL VINYL ALCOHOL ETHERS AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2022-03-23 | — | — | EP | disclosed |
| US-9907854-B2 | Crosslinking reagents, macromolecules, therapeutic bioconjugates, and synthetic methods thereof | CellMosaic, Inc. (US) | 2018-03-06 | — | — | US | disclosed |
| US-20180043028-A1 | POLYMER-SUNITINIB CONJUGATES | NEKTAR THERAPEUTICS | 2018-02-15 | — | — | US | disclosed |
| US-8182841-B2 | Amniotic membrane preparations and purified compositions and anti-inflammation methods | TISSUE TECH, INC. (US) | 2012-05-22 | — | — | US | disclosed |
| US-20120088927-A1 | Methods for the Formation of Hydrogels Using Thiosulfonate Compositions and Uses Thereof | NEKTAR THERAPEUTICS (US) | 2012-04-12 | — | — | US | disclosed |
| US-8097695-B2 | Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof | NEKTAR THERAPEUTICS (US) | 2012-01-17 | — | — | US | disclosed |
| US-20100216915-A1 | Levulinic acid ester derivatives as reactive plasticizers and coalescent solvents | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2010-08-26 | — | — | US | disclosed |
| US-7659234-B2 | Personal care compositions containing quaternary ammonium trihydroxy substituted dipropyl ether | CONOPCO, INC. (US) | 2010-02-09 | — | — | US | disclosed |
| US-20100004424-A1 | Methods for the Formation of Hydrogels Using Thiosulfonate Compositions and Uses Thereof | NEKTAR THERAPEUTICS (US) | 2010-01-07 | — | — | US | disclosed |
| US-20070231401-A1 | Amniotic membrane preparations and purified compositions and anti-inflammation methods | BIO-TISSUE, INC. (US) | 2007-10-04 | — | — | US | disclosed |
| US-20070212324-A1 | PERSONAL CARE COMPOSITIONS CONTAINING QUATERNARY AMMONIUM TRIHYDROXY SUBSTITUTED DIPROPYL ETHER | CONOPCO, INC., D/B/A UNILEVER (US) | 2007-09-13 | — | — | US | disclosed |
| US-6764979-B2 | INCREASING PENETRATION OF IOXYNIL OR DERIVATIVE THEREOF INTO LEAVES OF PLANT BY CONTACTING WITH COMPOSITION COMPRISING WATER, IOXYNIL COMPOUND, AND ALKOXYLATED ALCOHOLS OR ALKOXYLATED FATTY ACID ESTERS | COGNIS DEUTSCHLAND GMBH & CO. KG (DE) | 2004-07-20 | — | — | US | disclosed |
| US-20030158044-A1 | Aqueous herbicidal agent | COGNIS IP MANAGEMENT GMBH (DE) | 2003-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230372500-A1 | MULTI-ARM POLYMER CONJUGATES OF TLR AGONIST COMPOUNDS AND RELATED IMMUNOTHERAPEUTIC TREATMENT METHODS | TLR7, TLR8, TLR3 | USP2 1495/4885KDM4E 2064/4885LMNA 4463/4885 |
| US-11813241-B2 | Multi-arm polymeric prodrug conjugates of taxane-based compounds | PAICS, FOLR1, FOLR2 | USP2 3260/4885KDM4E 4126/4885LMNA 1880/4885 |
| US-20100216915-A1 | Levulinic acid ester derivatives as reactive plasticizers and coalescent solvents | EPM2A, ALAD, GABRD | USP2 2095/4885KDM4E 2014/4885LMNA 908/4885 |
| US-11744898-B2 | Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods | TLR7, TLR8, TLR3 | USP2 1658/4885KDM4E 2121/4885LMNA 4373/4885 |
| US-20100004424-A1 | Methods for the Formation of Hydrogels Using Thiosulfonate Compositions and Uses Thereof | TST, CTH, MPST | USP2 884/4885KDM4E 3761/4885LMNA 4748/4885 |
| US-20180043028-A1 | POLYMER-SUNITINIB CONJUGATES | FLT4, TEK, TIE1 | USP2 2764/4885KDM4E 1439/4885LMNA 4325/4885 |
| US-20120088927-A1 | Methods for the Formation of Hydrogels Using Thiosulfonate Compositions and Uses Thereof | TST, CTH, MPST | USP2 884/4885KDM4E 3761/4885LMNA 4748/4885 |
| US-20070212324-A1 | PERSONAL CARE COMPOSITIONS CONTAINING QUATERNARY AMMONIUM TRIHYDROXY SUBSTITUTED DIPROPYL ETHER | USP39, USP36, USP47 | USP2 146/4885KDM4E 190/4885LMNA 3367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.